GBS (GBS) Competitors $1.43 -0.01 (-0.70%) (As of 12/27/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends GBS vs. NSPR, WOK, APYX, HSAQ, ICCM, NVNO, INO, LUCD, CTSO, and TMDIFShould you be buying GBS stock or one of its competitors? The main competitors of GBS include InspireMD (NSPR), WORK Medical Technology Group LTD Ordinary Shares (WOK), Apyx Medical (APYX), Health Sciences Acquisitions Co. 2 (HSAQ), IceCure Medical (ICCM), enVVeno Medical (NVNO), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), Cytosorbents (CTSO), and Titan Medical (TMDIF). These companies are all part of the "surgical & medical instruments" industry. GBS vs. InspireMD WORK Medical Technology Group LTD Ordinary Shares Apyx Medical Health Sciences Acquisitions Co. 2 IceCure Medical enVVeno Medical Inovio Pharmaceuticals Lucid Diagnostics Cytosorbents Titan Medical GBS (NYSE:GBS) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability, media sentiment, risk and valuation. Does the media favor GBS or NSPR? In the previous week, InspireMD had 1 more articles in the media than GBS. MarketBeat recorded 1 mentions for InspireMD and 0 mentions for GBS. InspireMD's average media sentiment score of 0.59 beat GBS's score of -0.40 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment GBS Neutral InspireMD Positive Which has more volatility and risk, GBS or NSPR? GBS has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Which has preferable valuation & earnings, GBS or NSPR? GBS has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than GBS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGBS$440K48.39-$8.31M-$0.56-2.55InspireMD$6.82M10.29-$19.92M-$0.75-3.59 Do insiders and institutionals believe in GBS or NSPR? 2.8% of GBS shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 0.3% of GBS shares are held by company insiders. Comparatively, 29.7% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer GBS or NSPR? InspireMD received 4 more outperform votes than GBS when rated by MarketBeat users. CompanyUnderperformOutperformGBSN/AN/AInspireMDOutperform Votes44.82%Underperform Votes7995.18% Do analysts prefer GBS or NSPR? InspireMD has a consensus price target of $4.75, indicating a potential upside of 76.58%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than GBS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GBS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is GBS or NSPR more profitable? GBS has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat GBS's return on equity.Company Net Margins Return on Equity Return on Assets GBSN/A -85.64% -54.42% InspireMD -413.96%-69.42%-57.68% SummaryInspireMD beats GBS on 10 of the 17 factors compared between the two stocks. Ad StocksToTradeTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’s promise, and a secret Elon project set to revolutionize a $23 Trillion market…Click here to review Tim’s special Holiday offer before it’s too late. Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$21.29M$4.36B$5.21B$19.26BDividend YieldN/A41.46%4.96%3.63%P/E Ratio-2.5525.0087.2140.76Price / Sales48.3951.391,140.2918.84Price / CashN/A43.3543.2721.25Price / Book3.257.084.875.31Net Income-$8.31M$13.64M$120.16M$989.46M7 Day Performance10.00%2.96%2.06%1.03%1 Month Performance-10.63%-1.69%16.40%-4.76%1 Year Performance323.20%37.75%29.04%12.09% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.43-0.7%N/A+312.7%$21.29M$440,000.00-2.557Gap DownNSPRInspireMD2.3712 of 5 stars$2.95-1.7%$4.75+61.0%-4.3%$76.95M$6.82M-3.9350Analyst ForecastWOKWORK Medical Technology Group LTD Ordinary SharesN/A$4.84+15.2%N/AN/A$70.18M$9.86M0.00226Gap DownAPYXApyx Medical2.3573 of 5 stars$1.66+5.7%N/A-37.4%$62.49M$48.54M-2.00270Gap UpHSAQHealth Sciences Acquisitions Co. 2N/A$4.92+2.5%N/A-54.4%$55.16MN/A0.004ICCMIceCure Medical2.9013 of 5 stars$1.12flat$2.70+141.1%+4.7%$51.09M$3.67M-3.8671Short Interest ↓Positive NewsNVNOenVVeno Medical2.4958 of 5 stars$2.91+16.9%N/A-38.7%$51.03MN/A-2.2619Positive NewsINOInovio Pharmaceuticals3.5287 of 5 stars$1.79-2.7%$38.00+2,022.9%-97.5%$46.72M$203,413.00-0.52127Short Interest ↑Negative NewsLUCDLucid Diagnostics3.6999 of 5 stars$0.78-0.8%$3.63+367.7%-44.0%$46.00M$4.19M-0.6870Short Interest ↓Gap UpCTSOCytosorbents2.608 of 5 stars$0.84-8.4%$2.00+138.5%-15.3%$45.84M$33.79M-2.33186Analyst ForecastGap DownHigh Trading VolumeTMDIFTitan MedicalN/A$0.40-7.7%N/A+474.2%$45.62M$17.63M-0.324News CoverageGap Down Related Companies and Tools Related Companies InspireMD Alternatives WORK Medical Technology Group LTD Ordinary Shares Alternatives Apyx Medical Alternatives Health Sciences Acquisitions Co. 2 Alternatives IceCure Medical Alternatives enVVeno Medical Alternatives Inovio Pharmaceuticals Alternatives Lucid Diagnostics Alternatives Cytosorbents Alternatives Titan Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GBS) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersTrading 5-7 Stocks to Profit $1,300 a Day?If you want a straightforward, faster, and potentially more reliable way to trade… Learn this strategy by w...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredFastest Way To Build Wealth From Trump Stock MELT UPDonald Trump is about to ignite the biggest… and fastest… stock market boom in American history. He will be...Banyan Hill Publishing | SponsoredElon Musk’s next tweet could help pay for your retirementElon Musk says the government is going bankrupt. Seniors are getting crushed by inflation.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
